Medication utilization and annual health care costs in patients with type 2 diabetes mellitus before and after bariatric surgery

Archives of Surgery

Volumn 145, Issue 8, 2010, Pages 726-731

  Makary, Martin A ^a,b   Clarke, Jeanne M ^b   Shore, Andrew D ^a   Magnuson, Thomas H ^b   Richards, Thomas ^a   Bass, Eric B ^b   Dominici, Francesca ^a   Weiner, Jonathan P ^a   Wu, Albert W ^a,b   Segal, Jodi B ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA GLUCOSIDASE INHIBITOR; INSULIN; MEGLITINIDE; METFORMIN; SULFONYLUREA; ANTIDIABETIC AGENT;

ADULT; ARTICLE; BARIATRIC SURGERY; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HEALTH SERVICE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POSTOPERATIVE CARE; PRIORITY JOURNAL; SURGICAL TECHNIQUE; CLINICAL TRIAL; COMPLICATION; COST OF ILLNESS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; DRUG UTILIZATION; ECONOMICS; MIDDLE AGED; MULTICENTER STUDY; OBESITY, MORBID; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; UNITED STATES;

BARIATRIC SURGERY; COST OF ILLNESS; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DRUG UTILIZATION; FEMALE; HEALTH CARE COSTS; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; OBESITY, MORBID; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 77955560922     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.2010.150     Document Type: Article

References (24)

1. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414(6865):782-787. (Pubitemid 34000780)
2. Leibson CL, Williamson DF, Melton LJ III, et al. Temporal trends in BMI among adults with diabetes. Diabetes Care. 2001;24(9):1584-1589. (Pubitemid 33716453)
3. Norris SL, Zhang X, Avenell A, et al. Long-term effectiveness of lifestyle and behavioral weight loss interventions in adults with type 2 diabetes: ameta-analysis. Am J Med. 2004;117(10):762-774.
4. Ferchak CV, Meneghini LF. Obesity, bariatric surgery and type 2 diabetes - a systematic review. Diabetes Metab Res Rev. 2004;20(6):438-445. (Pubitemid 40028643)
5. Saaddine JB, Engelgau MM, Beckles GL, Gregg EW, Thompson TJ, Narayan KM. A diabetes report card for the United States: quality of care in the 1990s. Ann Intern Med. 2002;136(8):565-574.
6. Sjöström L, Lindroos AK, Peltonen M, et al; Swedish Obese Subjects Study Scientific Group. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683-2693.
7. Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357(8):753-761.
8. Kopp HP, Kopp CW, Festa A, et al. Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome inmorbidly obese patients. Arterioscler Thromb Vasc Biol. 2003;23(6):1042-1047. (Pubitemid 36713558)
9. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724-1737. (Pubitemid 39346675)
10. Torquati A, Lutfi R, Abumrad N, Richards WO. Is Roux-en-Y gastric bypass surgery the most effective treatment for type 2 diabetes mellitus in morbidly obese patients? J Gastrointest Surg. 2005;9(8):1112-1118. (Pubitemid 41564107)
11. Cossu ML, Noya G, Tonolo GC, et al. Duodenal switch without gastric resection: results and observations after 6 years. Obes Surg. 2004;14(10):1354-1359. (Pubitemid 39658322)
12. Rubino F, Gagner M, Gentileschi P, et al. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg. 2004;240(2):236-242. (Pubitemid 38963013)
13. Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222(3):339-352.
14. Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299(3):316-323. (Pubitemid 351159368)
15. MacDonald KG Jr, Long SD, Swanson MS, et al. The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. J Gastrointest Surg. 1997;1(3):213-220.
16. Pories WJ, MacDonald KG Jr, Morgan EJ, et al. Surgical treatment of obesity and its effect on diabetes: 10-y follow-up. Am J Clin Nutr. 1992;55(2)(suppl):582S-585S.
17. le Roux CW, Aylwin SJ, Batterham RL, et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg. 2006;243(1):108-114.
18. Parikh M, Ayoung-Chee P, Romanos E, et al. Comparison of rates of resolution of diabetes mellitus after gastric banding, gastric bypass, and biliopancreatic diversion. J Am Coll Surg. 2007;205(5):631-635. (Pubitemid 47615490)
19. Zingmond DS, McGory ML, Ko CY. Hospitalization before and after gastric bypass surgery. JAMA. 2005;294(15):1918-1924.
20. Haslam DW, James WP. Obesity. Lancet. 2005;366(9492):1197-1209.
21. Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world - a growing challenge. N Engl J Med. 2007;356(3):213-215. (Pubitemid 46143224)
22. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047-1053.
23. Fagot-Campagna A, Pettitt DJ, Engelgau MM, et al. Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective. J Pediatr. 2000;136(5):664-672. (Pubitemid 30318399)
24. Brandle M, Zhou H, Smith BR, et al. The direct medical cost of type 2 diabetes. Diabetes Care. 2003;26(8):2300-2304. (Pubitemid 36993316)